Literature DB >> 18500392

The roles of the proteasome pathway in signal transduction and neurodegenerative diseases.

Jiao-Jiao Chen1, Fang Lin, Zheng-Hong Qin.   

Abstract

There are two degradation systems in mammalian cells, autophagy/lysosomal pathway and ubiquitin-proteasome pathway. Proteasome is consist of multiple protein subunits and plays important roles in degradation of short-lived cellular proteins. Recent studies reveal that proteasomal degradation system is also involved in signal transduction and regulation of various cellular functions. Dysfunction or dysregulation of proteasomal function may thus be an important pathogenic mechanism in certain neurological disorders. This paper reviews the biological functions of proteasome in signal transduction and its potential roles in neurodegenerative diseases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18500392      PMCID: PMC5552546          DOI: 10.1007/s12264-008-0183-6

Source DB:  PubMed          Journal:  Neurosci Bull        ISSN: 1995-8218            Impact factor:   5.203


  89 in total

Review 1.  Ubiquitin-mediated proteolysis: biological regulation via destruction.

Authors:  A Ciechanover; A Orian; A L Schwartz
Journal:  Bioessays       Date:  2000-05       Impact factor: 4.345

Review 2.  Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity.

Authors:  M Karin; Y Ben-Neriah
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

Review 3.  Deadly encounter: ubiquitin meets apoptosis.

Authors:  Veronika Jesenberger; Stefan Jentsch
Journal:  Nat Rev Mol Cell Biol       Date:  2002-02       Impact factor: 94.444

4.  Proteasomal degradation of tau protein.

Authors:  Della C David; Robert Layfield; Louise Serpell; Yolanda Narain; Michel Goedert; Maria Grazia Spillantini
Journal:  J Neurochem       Date:  2002-10       Impact factor: 5.372

5.  Inefficient degradation of truncated polyglutamine proteins by the proteasome.

Authors:  Carina I Holmberg; Kristine E Staniszewski; Kwame N Mensah; Andreas Matouschek; Richard I Morimoto
Journal:  EMBO J       Date:  2004-10-07       Impact factor: 11.598

Review 6.  Proteolysis: from the lysosome to ubiquitin and the proteasome.

Authors:  Aaron Ciechanover
Journal:  Nat Rev Mol Cell Biol       Date:  2005-01       Impact factor: 94.444

7.  Nuclear factor-kappa B contributes to excitotoxin-induced apoptosis in rat striatum.

Authors:  Z H Qin; Y Wang; M Nakai; T N Chase
Journal:  Mol Pharmacol       Date:  1998-01       Impact factor: 4.436

Review 8.  NF-kappaB activation: the I kappaB kinase revealed?

Authors:  I Stancovski; D Baltimore
Journal:  Cell       Date:  1997-10-31       Impact factor: 41.582

9.  Peptidylglutamyl-peptide hydrolase activity of the multicatalytic proteinase complex: evidence for a new high-affinity site, analysis of cooperative kinetics, and the effect of manganese ions.

Authors:  H Djaballah; A J Rivett
Journal:  Biochemistry       Date:  1992-04-28       Impact factor: 3.162

10.  Proteasome impairment does not contribute to pathogenesis in R6/2 Huntington's disease mice: exclusion of proteasome activator REGgamma as a therapeutic target.

Authors:  John S Bett; Geoffrey M Goellner; Ben Woodman; Gregory Pratt; Martin Rechsteiner; Gillian P Bates
Journal:  Hum Mol Genet       Date:  2005-11-25       Impact factor: 6.150

View more
  10 in total

Review 1.  Ischemic conditioning-induced endogenous brain protection: Applications pre-, per- or post-stroke.

Authors:  Yuechun Wang; Cesar Reis; Richard Applegate; Gary Stier; Robert Martin; John H Zhang
Journal:  Exp Neurol       Date:  2015-04-18       Impact factor: 5.330

2.  Cellular stress responses, mitostress and carnitine insufficiencies as critical determinants in aging and neurodegenerative disorders: role of hormesis and vitagenes.

Authors:  Vittorio Calabrese; Carolin Cornelius; Anna Maria Giuffrida Stella; Edward J Calabrese
Journal:  Neurochem Res       Date:  2010-11-13       Impact factor: 3.996

3.  The regulation of N-terminal Huntingtin (Htt552) accumulation by Beclin1.

Authors:  Jun-chao Wu; Lin Qi; Yan Wang; Kimberly B Kegel; Jennifer Yoder; Marian Difiglia; Zheng-hong Qin; Fang Lin
Journal:  Acta Pharmacol Sin       Date:  2012-04-30       Impact factor: 6.150

Review 4.  Cysteine cathepsins in neurological disorders.

Authors:  Anja Pišlar; Janko Kos
Journal:  Mol Neurobiol       Date:  2013-11-15       Impact factor: 5.590

Review 5.  The neuroprotective mechanism of brain ischemic preconditioning.

Authors:  Xiao-qian Liu; Rui Sheng; Zheng-hong Qin
Journal:  Acta Pharmacol Sin       Date:  2009-07-20       Impact factor: 6.150

6.  PARP-1 modulates amyloid beta peptide-induced neuronal damage.

Authors:  Sara Martire; Andrea Fuso; Dante Rotili; Italo Tempera; Cesare Giordano; Ivana De Zottis; Alessia Muzi; Patrizia Vernole; Grazia Graziani; Emanuela Lococo; Martina Faraldi; Bruno Maras; Sigfrido Scarpa; Luciana Mosca; Maria d'Erme
Journal:  PLoS One       Date:  2013-09-24       Impact factor: 3.240

Review 7.  Protein clearance strategies for disease intervention.

Authors:  Franziska Hommen; Saygın Bilican; David Vilchez
Journal:  J Neural Transm (Vienna)       Date:  2021-10-23       Impact factor: 3.575

8.  The Role of SETBP1 in Gastric Cancer: Friend or Foe.

Authors:  Fujin Fang; Chengyou Liu; Qiong Li; Rui Xu; Tiantian Zhang; Xiaobing Shen
Journal:  Front Oncol       Date:  2022-07-11       Impact factor: 5.738

Review 9.  Terminal Phenoxy Group as a Privileged Moiety of the Drug Scaffold-A Short Review of Most Recent Studies 2013-2022.

Authors:  Paweł Kozyra; Monika Pitucha
Journal:  Int J Mol Sci       Date:  2022-08-09       Impact factor: 6.208

10.  Neuroprotective Effect of Simvastatin via Inducing the Autophagy on Spinal Cord Injury in the Rat Model.

Authors:  Kai Gao; Guannan Wang; Yansong Wang; Donghe Han; Jing Bi; Yajiang Yuan; Tianchen Yao; Zhanghui Wan; Haihong Li; Xifan Mei
Journal:  Biomed Res Int       Date:  2015-10-11       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.